A case of erythema multiforme major following administration of ciprofloxacin ophthalmic drops by Arnold, Morgan & Wilkerson, Michael
UC Davis
Dermatology Online Journal
Title
A case of erythema multiforme major following administration of ciprofloxacin ophthalmic 
drops
Permalink
https://escholarship.org/uc/item/49k2k7xt
Journal
Dermatology Online Journal, 23(10)
Authors
Arnold, Morgan
Wilkerson, Michael
Publication Date
2017
License
CC BY-NC-ND 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Volume 23 Number 10 | October 2017 
DOJ 23 (10): 8
- 1 - 
Dermatology Online Journal  ||  Case Presentation
Morgan Arnold BS1, Michael Wilkerson MD2
Affiliations: 1University of Texas Medical Branch at Galveston School of Medicine, Galveston, Texas, 2University of Texas Medical 
Branch at Galveston Department of Dermatology Galveston, Texas
Corresponding Author: Michael Wilkerson MD, Department of Dermatology, University of Texas Medical Branch at Galveston, Galveston, 
Texas, Email: mgwilker@utmb.edu
A case of erythema multiforme major following 
administration of ciprofloxacin ophthalmic drops
Keywords: drug-induced, eye drops, ophthalmic drops, 
erythema multiforme, fluoroquinolones
Introduction
Erythema multiforme major (EMM) is an acute, self-
limited, type IV hypersensitivity reaction to certain 
drugs, pathogens, and other allergens. It is thought 
to lie on a spectrum with Stevens-Johnson syndrome 
and toxic epidermal necrolysis and presents with 
characteristic targetoid lesions with mucosal erosions 
or bullae. Indeed, currently it is considered by several 
investigators to be synonymous with Stevens-
Johnson syndrome having less than 10 percent body 
surface area involvement and 2 mucous membranes 
affected [1]. Since the terminology for this spectrum 
of diseases is still debated, we will refer to our patient’s 
diagnosis as “EMM” because her clinical features (e.g., 
targetoid lesions, oral mucosal involvement) align 
closely with the classic description of EMM [2]. Herein 
we describe an unusual case of EMM triggered by the 
use of ciprofloxacin ophthalmic drops.
Case Synopsis
A 49-year-old woman presented to the emergency 
department for evaluation of sudden-onset diffuse 
rash and pruritus. The patient had an extensive 
past medical history including hypertension, Type 
II diabetes mellitus requiring left-sided below-
knee amputation, Stage IV chronic kidney disease, 
asthma, congestive heart failure, and coronary artery 
disease. Notably, after a 2009 quadruple bypass 
graft she had an allergic reaction to the sternotomy 
wires leading to wound dehiscence and requiring 
removal of a majority of her sternum and subsequent 
reconstructive surgery. One week prior to admission 
the patient developed injected sclera and eye pain 
bilaterally. Her primary care physician diagnosed her 
with conjunctivitis and prescribed ciprofloxacin eye 
drops three times daily. Despite use of these eye drops, 
her eye pain progressively worsened throughout the 
week. She took diphenhydramine 12.5 mg twice 
daily without improvement. On the day of admission, 
the patient awakened with odynophagia, diffuse 
rash, and intense pruritus. The rash started on her 
stump and spread over the rest of her body during 
the course of the day. She had a cold three weeks 
prior to admission but it resolved without treatment. 
Besides the eye drops, the patient was taking no new 
medications. Family history revealed the presence 
of systemic lupus erythematosus in the patient’s 
mother.
Abstract
A 49-year old woman was hospitalized for generalized 
rash and pruritus following the administration of 
ophthalmic drops containing ciprofloxacin to treat 
conjunctivitis. Physical examination demonstrated 
diffuse erythematous papules and plaques with a 
targetoid appearance, injected sclera, and multiple 
erosions in the oropharynx. Skin biopsy confirmed 
a diagnosis of erythema multiforme major. The eye 
drops were discontinued and supportive treatment 
was initiated; the patient recovered in four weeks and 
was discharged from the hospital. Although cases 
such as this are rare, it is important that physicians take 
a thorough medication history from all patients with 
suspected erythema multiforme, including topical 
and ophthalmic medications. Prompt discontinuation 
of the offending agent can hasten patient recovery 
and optimize outcomes.
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On physical examination, the patient demonstrated 
diffuse, symmetric, annular, erythematous papules 
and plaques with dusky centers (Figure 1). Sclera 
were injected bilaterally. Oral examination revealed 
mucositis with multiple erosions present (Figure 2). 
Laboratory values were significant for an elevated 
erythrocyte sedimentation rate of 52 mm/HR (RR 
0-20 mm/HR) on the day of admission. Measurement 
of serum Mycoplasma IgM was within normal limits. 
Chest X-rays were taken three times during the 
patient’s admission; all chest X-rays were negative. 
Punch biopsy of lesions on the patient’s right 
shoulder and right wrist revealed interface dermatitis 
with central areas of full-thickness epidermal necrosis 
consistent with EMM (Figure 3).
After the diagnosis of EMM was confirmed by biopsy, 
the ciprofloxacin eye drops were discontinued and 
the patient was treated with topical triamcinolone 
0.1% ointment twice daily on the body and lips and 
hydrocortisone 1% ointment twice daily on the face 
until the lesions resolved. On hospital day 22 the 
patient was discharged with significant improvement 
of her symptoms.
Case Discussion
Erythema multiforme major is a cutaneous 
hypersensitivity reaction that may be caused by 
various agents, such as drugs, diseases, or household 
products. Common culprits include herpes simplex 
virus infections, M. pneumoniae infections, 
antibiotics, sulfonamides and antiepileptics [3]. 
Thought to lie on a spectrum with Stevens-Johnson 
syndrome (SJS) and toxic epidermal necrolysis (TEN), 
erythema multiforme major severe enough to require 
hospitalization has an incidence of less than 7.4 per 
106 person-years [4]. The disease often begins with 
prodromal symptoms such as cough, fever, malaise, 
and headache, followed by the eruption of a rash. 
The skin lesions of EMM classically begin with discoid, 
erythematous macules that quickly become papular. 
These edematous papules evolve into the targetoid 
lesions characteristic of EMM. These lesions typically 
erupt on the extremities and move centrally, often 
appearing on the mucosa as well as the skin. Given 
Figure 1.Diffuse, pruritic, erythematous papules and plaques 
with dusky centers on right leg.
Figure 2. Mucosal erosions causing odynophagia.
Figure 3. Punch biopsy of the patient’s right shoulder revealing 
interface dermatitis with central areas of full-thickness epidermal 
necrosis. H&E, 200.
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the extensive mucosal and cutaneous involvement 
of EMM, numerous complications may arise. The 
most common complications are ocular, including 
keratitis, loss of vision, and uveitis. Myocardial, renal, 
hematologic, and pulmonary complications are rare 
but have been reported. Attacks of EMM are self-
limited, typically lasting 1-6 weeks [3].
Fluoroquinolones such as ciprofloxacin, levofloxacin 
and norfloxacin are well-documented triggers of 
EMM/SJS/TEN [5-7] However, in most instances, 
the inciting fluoroquinolone is administered orally 
or intravenously. Several documented cases exist 
in which sulfacetamide ophthalmic drops resulted 
in toxic epidermal necrolysis [8, 9]. To the best of 
our knowledge, only two other cases of EMM/SJS/
TEN induced by fluoroquinolone eye drops have 
been reported [10, 11]. The first of these cases was 
a 20-year-old man who developed TEN 48 hours 
after starting ofloxacin eye drops for a left-sided 
hordeolum [10]. In the second case, a 12-year-old 
girl began having symptoms of SJS (e.g., mouth 
ulcers, conjunctival injection) 2 days following the 
administration of ofloxacin eye drops; she presented 
for treatment 2 days after the onset of symptoms [11]. 
In both cases, the patients had no chronic medical 
conditions [10, 11], although the male patient had 
a history of lip swelling during treatment of a lower 
respiratory tract infection with oral ciprofloxacin 
three years prior [10]. Neither patient reported using 
any medications besides the ophthalmic drops [10, 
11]. In our case, the identification of the eye drops as 
the causative agent was supported by the temporal 
association between the onset of symptoms and the 
administration of the eye drops and the lack of any 
other medications recently started by the patient. 
Mycoplasma-induced EMM was considered owing 
to the patient’s recent history of a “cold,” although in 
EMM due to Mycoplasma infection, mucosal lesions 
rather than cutaneous lesions often predominate. 
However, acute Mycoplasma infection was ruled out 
by normal serum Mycoplasma IgM levels. Complete 
withdrawal of the offending agent, along with 
copious use of topical corticosteroids, resulted in the 
patient’s remission.
Conclusion
Erythema multiforme major should be considered 
in any patient with a sudden, diffuse eruption of 
pruritic targetoid lesions after the administration 
of fluoroquinolone ophthalmic drops. The 
pathogenesis of EMM is unclear, but it is thought to 
be the result of a cutaneous type-IV hypersensitivity 
reaction. Laboratory findings are usually non-specific 
[3]. Histopathologic evaluations of EMM show focal 
liquefactive degeneration of the epidermal basal 
zone along with inflammatory changes such as 
exocytosis and spongiosis [12]. Because such a wide 
array of agents may lead to EMM, it is important 
that physicians be aware of the potential for even 
topical medications to cause severe drug reactions. 
Ciprofloxacin ophthalmic drops should be added to 
the list of causative agents that may induce EMM, 
and dermatologists should be aware of this to avoid 
misdiagnosis.
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